FilingSEC EDGAR8-K
Immunic hosts Relapsing Multiple Sclerosis Research and Development Day webinar.
· SEC accepted
StageOngoing
Filing content
Immunic held a webinar on September 9, 2026, to present updates on its Relapsing Multiple Sclerosis research and development programs.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…